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Abstract
Background: Anopheles funestus is one of the major malaria vectors in tropical Africa, notably in Senegal. The highly
anthropophilic and endophilic behaviours of this mosquito make it a good target for vector control operations
through the use of insecticide treated nets, long-lasting insecticide nets and indoor residual spraying. However,
little is known about patterns of resistance to insecticides and the underlying resistance mechanisms in field
populations of this vector in Senegal.
Methods: Here, we assessed the susceptibility status of An. funestus populations from Gankette Balla, located in
northern Senegal and investigated the potential resistance mechanisms.
Results: WHO bioassays indicated that An. funestus is resistant to lambda-cyhalothrin 0.05 % (74.64 % mortality),
DDT 4 % (83.36 % mortality) and deltamethrin 0.05 % (88.53 % mortality). Suspected resistance was observed to
permethrin 0.75 % (91.19 % mortality), bendiocarb 0.1 % (94.13 % mortality) and dieldrin 4 % (96.41 % mortality).
However, this population is fully susceptible to malathion 5 % (100 % mortality) and fenitrothion 1 % (100 % mortality).
The microarray and qRT-PCR analysis indicated that the lambda-cyhalothrin resistance in Gankette Balla is conferred
by metabolic resistance mechanisms under the probable control of cytochrome P450 genes among which CYP6M7
is the most overexpressed. The absence of overexpression of the P450 gene, CYP6P9a, indicates that the resistance
mechanism in Senegal is different to that observed in southern Africa.
Conclusions: This study represents the first report of pyrethroid and DDT resistance in An. funestus from Senegal
and shows that resistance to insecticides is not only confined to An. gambiae as previously thought. Therefore,
urgent action should be taken to manage the resistance in this species to ensure the continued effectiveness of
malaria control.
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Background
The burden of malaria remains heaviest in the WHO
African region, where an estimated 90 % of all malaria
deaths occur, and in children aged under five years, who
account for 78 % of all deaths [1]. In Senegal, malaria is
a major cause of morbidity and mortality and a high
priority for the government, even though the number of
reported cases of malaria has dropped significantly since
2007–2008 [2]. As in many African countries, malaria
control in Senegal relies heavily on vector control
through the use of long-lasting insecticide nets (LLINs)
and indoor residual spraying (IRS). However, resistance
to the main insecticides in the major malaria vectors
such as Anopheles funestus is threatening the success of
these control interventions. Resistance to different clas-
ses of insecticides used in public health is increasingly
reported across Africa in An. funestus with fear that this
could disrupt control programs against this vector.
Indeed, resistance to pyrethroids, DDT and carbamates
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has been reported in different regions of Africa including
southern Africa [3–6], Central Africa [7], East Africa
[8, 9] and West Africa [10, 11]. In Senegal, pyrethroid
resistance until recently was mainly reported in An.
gambiae [12–14] while little is known about the suscep-
tibility of An. funestus to insecticides. Senegal is cur-
rently scaling up its malaria control program through
LLINs and IRS [15, 16]. It is crucial that information on
susceptibility to main insecticides used in public health and
the underlying mechanisms be investigated. This will prop-
erly inform control programs of the most suitable insecti-
cides to use and facilitate the design of appropriate
resistance management strategies. In this study, we report
the assessment of the susceptibility of one An. funestus
population from northern Senegal to several insecticides
used in public health and also investigate the underlying
molecular mechanisms conferring resistance to lambda-
cyhalothrin, a key pyrethroid insecticide used for IRS. This
information will fill the gap in our knowledge on the resist-
ance distribution in An. funestus and help to improve future
control programs on this species in Senegal.
Methods
Study site and mosquito collection
Blood-fed An. funestus adult females resting indoor were
collected in houses between 7.00 am and 15.00 pm in
November 2011, in Gankette Balla (15°58′N, 15°55′W),
which is located in the Lake Guiers area, in northern
Senegal, West Africa. Blood-fed and gravid mosquitoes
resting inside houses were collected using aspirators and
torches and kept in small cups, covered by a non-treated
net, until fully gravid and transported to the insectary
where they were allowed to lay eggs [17] and hatch in
larvae bowls for rearing. The egg batches were pooled
and reared together and the F1 adults generated were
randomly mixed in cages for subsequent experiments.
Species identification
All females used for individual oviposition were morpho-
logically identified as belonging to the An. funestus
group [18]. Genomic DNA was extracted from head and
thorax using the Livak protocol as previously described
[19]. A cocktail PCR was carried to confirm that all
females that laid eggs were An. funestus (s.s.) [20].
Adult mosquito susceptibility assays
Insecticide susceptibility assays were carried out using
2–5 day-old F1 adults following the WHO protocol [21].
Approximately 20–25 mosquitoes per tube with 4–6
replicates were exposed to insecticide-impregnated filter
paper for 1 h or control paper and then transferred to a
clean holding tube supplied with 10 % sugar and mortal-
ity was determined 24 h post-exposure. We tested the
following insecticides: the pyrethroids permethrin
(0.75 %), lambda-cyhalothrin (0.05 %) and deltamethrin
(0.05 %); the carbamate bendiocarb (0.01 %); the organo-
phosphate malathion (5 %) and fenitrothion (5 %) and
the organochlorines DDT (4 %) and dieldrin (4 %).
Microarray analysis
A custom microarray chip [3] containing 8 × 60 k probes
(60mer) (A-MEXP-2374) was used to identify the set of
genes associated with lambda-cyhalothrin resistance
[22]. RNA was extracted from three batches of 10 An.
funestus females that were 2–5 day-old from the following
sample sets: alive after exposure to 0.75 % lambda-
cyhalothrin (R); unexposed to insecticides and thus repre-
sentative of the wild-type population (C); and unexposed
mosquitoes from the fully susceptible laboratory strain
FANG (S). RNA was isolated using the Picopure RNA
isolation kit (Arcturus, Applied Biosystems, Carlsbad,
CA, USA). The quantity and quality of extracted RNA
were assessed using a NanoDrop ND1000 spectropho-
tometer (Thermo Fisher Scientific, Waltham, MA, USA)
and a Bioanalyzer (Agilent, Santa Clara, CA, USA), re-
spectively. cRNA of each sample was amplified using the
Agilent Quick Amp labeling kit (two-colour) following
the manufacturer’s protocol. cRNA from the resistant
samples (R) were labelled with cy5 dye and cRNA from
the control (C) were labelled with both cy3 and cy5,
whereas the susceptible strain FANG (S) was labelled
with the cy3 dye. cRNA quantity and quality were
checked after labelling using the NanoDrop spectropho-
tometer and Bioanalyzer. Labelled cRNAs were hybrid-
ized to the arrays for 17 h at 65 °C according to the
manufacturer’s protocol. Five hybridizations for each of
the comparisons (R-S, R-C and C-S) were carried out by
swapping the biological replicates. Microarray data were
analysed using Genespring GX 12.0 software. To identify
differentially expressed genes, a cut-off of 1.5 (R-C) and
2-fold-change (FC) (R-S and C-S) and a statistical signifi-
cance of P ≤ 0.05 with Benjamin-Hochberg correction
for multiple testing were applied.
Transcription profiling of candidate metabolic resistance
genes (qRT-PCR)
The main candidates resistance genes (Additional file 1:
Table S1) that were highly overexpressed from the micro-
array analysis were assessed by quantitative Reverse Tran-
scriptase PCR (qRT-PCR) to validate their expression
pattern using three biological replicates (10 females F1 for
each replicate) for lambda-cyhalothrin resistant mosqui-
toes (R) (alive after 24 h exposure to lambda-cyhalothrin),
control mosquitoes (C) (not exposed to any insecticide)
and susceptible FANG mosquitoes (S). One microgram of
total RNA from each of the three biological replicates for
resistant (R), control (C), and FANG (S) was used as a
template for cDNA synthesis using the Super-Script III
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(Invitrogen, Carlsbad, CA, USA) with oligo-dT20 and
RNase H, according to the manufacturer’s instructions. A
serial dilution of cDNA was used to establish standard
curves for each gene to assess PCR efficiency and
quantitative differences between samples. The q-RT-
PCR amplification was carried out in a MX3005 real-
time PCR system (Agilent, Santa Clara, CA, USA)
using Brilliant III Ultra-Fast SYBR Green QPCR Master
Mix (Agilent). A total of 10 ng of cDNA from each
sample was used as template in a three-step program
involving a denaturation at 95 °C for 3 min followed by
40 cycles of 10 s at 95 °C and 10 s at 60 °C and a last
step of 1 min at 95 °C, 30 s at 55 °C, and 30 s at 95 °C.
The relative expression and fold-change of each target
gene in R and C relative to S was calculated according
to the 2−ΔΔCT method incorporating PCR efficiency
[23] after normalization with the housekeeping RSP7
(ribosomal protein S7; AFUN007153-RA) and the Actin
(AFUN006819) genes.
Investigation of the role of knockdown resistance
mutation in lambda-cyhalothrin resistance
A fragment spanning a portion of the voltage-gated so-
dium channel gene (VGSC), including the 1014 codon
associated with resistance in An. gambiae, was ampli-
fied using the KdrFunF2/KdrFunR2 primers [9, 11, 24]
and sequenced (KdrFunR2) in ten field-collected An.
funestus female mosquitoes from Gankette Balla. PCR,
sequencing and analysis were carried out as previously
described [9, 11, 24].
Results
Mosquito collection
More than 450 blood-fed An. funestus females were
collected inside houses in the village of Gankette Balla
over a period of four days in November 2011. Around
150 laid eggs and all were confirmed to be An. funestus
(s.s.) by PCR.
Insecticide susceptibility
A total of 2,322 F1 An. funestus adults from Gankette
Balla were generated and exposed to various insecti-
cides (Additional file 2: Table S2). The bioassay per-
formed indicated that the An. funestus population
females were resistant to the type II pyrethroids
lambda-cyhalothrin and deltamethrin as well as to the
organochlorine DDT with mortality rates of 74.64 %,
88.53 % and 83.36 %, respectively. Suspected resis-
tance was observed to permethrin, bendiocarb and
dieldrin with mortality rates of 91.19 %, 94.13 % and
96.41 %, respectively. However, this population was
fully susceptible to the organophosphates malathion
and fenitrothion with a mortality rate of 100 %. The
males of this An. funestus population were generally
susceptible to exposed insecticides except for DDT
and lambda-cyhalothrin for which a moderate resist-
ance was observed with mortality rates of 90.30 % and
97.30 %, respectively (Fig. 1).
Genome-wide microarray-based transcription analysis of
lambda-cyhalothrin resistance
The total number of differentially expressed probes for
the comparison between lambda-cyhalothrin resistant
samples and the susceptible strain FANG (R-S) was
7,897 (3,789 overexpressed); 7,768 (4,055 overexpressed)
for the comparison between the control wild type sam-
ples (C) and the susceptible strain FANG (C-S); 115 (59
overexpressed) for the comparison between lambda-
cyhalothrin resistant samples and the control wild type
samples R-C) (Fig. 2). Fourteen probes were commonly
differentially expressed in the three types of comparison
(R-S, C-S and R-C). However, 5,388 probes were com-
monly differentially expressed in the R-S and C-S com-
parisons, whereas 44 and 18 probes were respectively
commonly differentially expressed in the pairs of com-
parisons R-S vs R-C and C-S vs R-C (Fig. 2).
Fig. 1 Insecticide resistance profile of Anopheles funestus populations from Gankette Balla
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Genes commonly overexpressed in R-S, C-S and
R-C comparisons
A probe for the CYP6M7 transcript, belonging to the
cytochrome P450 gene family, was the most commonly
overexpressed detoxification gene in the R-S (FC 101.64)
and C-S (FC 120.09) comparisons. This gene was also
significantly overexpressed in the R-C comparison but
with a much lower FC value (2.59) (Table 1). Other
cytochrome P450s genes that were also commonly overex-
pressed in the three comparisons were three other P450
genes including CYP6AH1 (combined_c1486), CYP304b1
and CYP4C36 (Afun007127). The transcripts Afun008293
and Afun009227 belonging to trypsin-related protease
and argininosuccinate lyase genes respectively, were
commonly highly overexpressed in R-S and C-S compari-
sons and significantly overexpressed in R-C. Transcripts
belonging to others detoxification genes family such
as glutathione transferase (GSTd3), abc transporter
(Afun015523), carboxylesterase (Afun011942) were also
significantly commonly overexpressed in the three com-
parisons (Table 1).
Genes commonly overexpressed in R-S and C-S
comparisons
Several detoxification genes or resistance-related genes
were commonly and significantly overexpressed in the R-S
and C-S comparison. A set of five transcripts belonging to
cytochrome P450s genes was commonly upregulated in
R-S and C-S, with CYP4H25 (FC 10.60; 4.99), CYP4C27
(FC9.98; 21.93) and CYP4H17 (FC9.82; 4.86) being the
most overexpressed (Table 1). A transcript (Afun007369)
with closest hit to CYP6P9b (92 %) was also overexpressed
in both R-S (FC4.04) and C-S (FC4.68). However, none of
the three probes designed for CYP6P9a was overexpressed
in this population, suggesting a significant difference with
southern African populations where this P450 is highly
overexpressed. Among the most commonly overexpressed
resistance-associated genes in R-S and C-S were the high
affinity GABA transporter (Afun009312) and an ankyrin
repeat domain protein (Afun005545). Noticeably, the
transcripts Afun008698 and AGAP000177-RA belong-
ing to heat shock protein 70 b2 and cuticle protein 7
genes successively were commonly overexpressed with
a high FC observed in C-S. Furthermore, several probes
from the GSTs gene family were also significantly and
commonly overexpressed in R-S and C-S in possible
association with the observed DDT resistance in this
population. These GST genes include the GSTd1-5 pre-
viously also reported in southern African populations
of An. funestus [4]. However, GSTe2, the major DDT
resistance gene observed in West and Central African
countries [4] is overexpressed in this Senegalese popu-
lation. The other detoxification or resistance related genes
are reported in Table 1 and Additional file 3: Table S3 and
include short-chain dehydrogenase, esterase b1, aldehyde
oxidase and chymotrypsin 1.
Genes commonly overexpressed in R-C and R-S comparisons
Only a limited number of genes were commonly over-
expressed in the two comparisons. Indeed, these genes
include: a single P450 (CYP9J5), three probes correspon-
ding to An. gambiae orthologous genes, one probe for
membrane-associated LPS-inducible TNF-alpha factor
protein and zinc metalloproteinase nas-12, successively
(Table 1). The top 50 of the most detoxification genes
overexpressed only in the comparisons R-S_L (Mosquitoes
resistant to lambda-cyhalothrin vs susceptible mosquitoes)
and R-C_L (Mosquitoes resistant to lambda-cyhalothrin
vs control mosquitoes) are presented in Additional file 4:
Tables S4 and Additional file 5: Table S5, respectively.
Fig. 2 Summary of probes differentially expressed in Lambda-cyhalothrin resistance
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Table 1 Transcripts from detoxification genes with lambda-cyhalothrin resistance upregulated in various comparisons (R-C, R-S
and C-S) in Gankette Balla
Probe name Transcript R-C R-S C-S Description
CUST_7663_PI426302897 CYP6M7 2.59 101.64 120.09 cytochrome p450
CUST_2949_PI406199769 combined_c1486 (CYP6AH1) 1.52 5.59 5.27 cytochrome p450
CUST_12197_PI426302897 CYP304b1 1.61 4.44 2.74 cytochrome p450
CUST_7127_PI426302897 Afun007127 (CYP4C36) 2.17 3.23 2.90 cytochrome p450
CUST_8293_PI426302897 Afun008293 1.78 79.77 63.27 trypsin-related protease
CUST_13921_PI426302897 Afun013921 2.21 34.28 25.55 chymotrypsin 1
CUST_8354_PI426302897 GSTD3 1.52 6.33 4.69 glutathione transferase (agap004382-pa)
CUST_7773_PI426302897 Afun007773 1.57 6.06 4.00 microsomal glutathione s-transferase
CUST_9227_PI426302897 Afun009227 1.79 29.78 42.82 argininosuccinate lyase
CUST_15523_PI426302897 Afun015523 1.55 8.39 8.34 abc transporter
CUST_14150_PI426302897 Afun014150 1.64 7.51 4.70 oxidative stress-induced growth
CUST_11942_PI426302897 Afun011942 1.63 3.47 3.20 carboxylesterase
CUST_376_PI406199788 gb-CYP4H25 10.60 4.99 cytochrome p450
CUST_12777_PI426302897 CYP4C27 9.98 21.93 cytochrome p450
CUST_4223_PI426302897 CYP4H17 9.82 4.86 cytochrome p450
CUST_12343_PI426302897 CYP4H17 6.46 3.90 cytochrome p450
CUST_12197_PI426302897 Afun012197 (CYP304B1) 4.44 2.74 cytochrome p450
CUST_7369_PI426302897 Afun007369 (CYP6P9b) 4.04 4.68 cytochrome p450
CUST_9312_PI426302897 Afun009312 25.95 38.54 high affinity gaba transporter
CUST_3489_PI406199769 combined_c1762 4.48 3.52 abc transporter
CUST_5545_PI426302897 Afun005545 14.97 18.72 ankyrin repeat domain protein
CUST_3386_PI426302897 Afun003386 5.50 4.54 ankyrin repeat domain-containing protein 50
CUST_10406_PI426302897 Afun010406 4.15 3.86 ankyrin repeat domain-containing protein 50
CUST_1930_PI426302897 Afun001930 4.39 3.88 ankyrin repeat-containing
CUST_3672_PI426302897 Afun003672 4.35 4.19 multiple ankyrin repeats single kh d. protein
CUST_1459_PI406199769 combined_c738 9.17 10.93 short-chain dehydrogenase
CUST_2520_PI406199772 CD578141.1 5.54 6.72 short-chain dehydrogenase
CUST_10105_PI426302897 Afun010105 3.38 2.44 short-chain dehydrogenase
CUST_12461_PI426302897 Afun012461 8.67 3.72 alcohol dehydrogenase
CUST_665_PI406199788 gb-NADH_dehyd 2.86 4.87 nadh dehydrogenase
CUST_10836_PI426302897 Esterase b1 7.33 3.75 esterase b1
CUST_11942_PI426302897 Afun011942 3.47 3.20 carboxylesterase
CUST_34_PI406199775 COEAE6O 2.41 2.05 carboxylesterase
CUST_13332_PI406199769 combined_c6826 2.06 2.33 esterase b1
CUST_295_PI406199798 AGAP000177-RA 7.06 16.73 cuticle protein 7
CUST_3736_PI406199772 CD577515.1 5.94 3.38 cuticle protein
CUST_8354_PI426302897 GSTD3 6.33 4.69 glutathione transferase (agap004382-pa)
CUST_7773_PI426302897 Afun007773 6.06 4.00 microsomal glutathione s-transferase
CUST_1870_PI406199769 combined_c944 4.25 2.09 microsomal glutathione s-transferase
CUST_10360_PI426302897 Afun010360 2.63 2.84 glucosyl glucuronosyl transferases
CUST_7499_PI426302897 GSTd1-5 2.55 2.48 glutathione transferase
CUST_8698_PI426302897 Afun008698 5.74 25.76 heat shock protein 70 b2
Samb et al. Parasites & Vectors  (2016) 9:449 Page 5 of 10
Genes commonly overexpressed in R-C and C-S comparisons
Only one transcript (combined_c4862) belonging to an-
kyrin unc44 gene was commonly overexpressed in R-C
(FC 1.51) and C-S (FC 2.53) comparisons (Table 1).
Genes commonly underexpressed in lambda-cyhalothrin
resistant mosquitoes
The detoxifying gene “CD578215.1” (cuticle protein) was
the most commonly underexpressed gene in the R-S_L
(FC 24.47), C-S (FC 56.22) and R-C_L (FC 1.52) compari-
sons. Other genes that were commonly underexpressed in
these three comparisons include: combined_c3712 (stress-
sensitive b), CD577548.1 (cytochrome c oxidase subunit
1), CD577574.1 (glutathione s-transferase) (Additional file
6: Table S6). The detoxifying gene “Afun013280” (carboxy-
peptidase n subunit 2) was the most commonly under
expressed gene in the R-S_L (FC 29.52) and C-S (FC
16.58) comparisons. Among the others detoxifying gene
families commonly underexpressed in R-S_L and CS, we
noted the presence of many probes from cytochrome c
oxidase subunit III and also from F0 ATP synthase sub-
unit 6 (Additional file 7: Table S7). The top 50 of the most
detoxification genes underexpressed only in the compari-
sons R-S_L and R-C_L are presented in Additional file 8:
Table S8 and Additional file 9: Table S9, respectively.
Validation of the microarray upregulation results by qRT-PCR
Quantitative reverse transcription PCR (q-RT-PCR) was
used to validate the microarray results for 11 of the most
overexpressed detoxification genes. These genes include
six cytochrome P450s (CYP6M7, CYP4H17, CYP4C27,
CYP6Z3, CYP9J11, CYP304b1), one dehydrogenase
(Combined_c738), two glutathione transferases (GSTd3,
GSTd1-5), one esterase (EstB1) and one aldehyde oxidase
(Ald oxi). The qRT-PCR results confirmed significantly
the overexpression of candidate genes at different levels.
Same to the microarray results, the cytochrome P450
CYP6M7 was the most overexpressed detoxification gene
(FC 11.69) in the R-S comparison (Fig. 3a). A significant
correlation between the qRT-PCR and microarray results
was observed (R2 = 0.358, P = 0.046) (Fig. 3b).
Role of knockdown resistance in lambda-cyhalothrin
resistance
PCR products were successfully amplified (994 bp) and
sequenced for a fragment (a portion of intron 19 and the
entire exon 20, domain II, segment 6) of the VGSC gene
in ten field-collected An. funestus female mosquitoes
from Gankette Balla. An 868 bp common sequence was
aligned for seven individuals detecting 15 polymorphic
sites (Fig. 4). Neither the L1014F kdr mutation nor the
L1014S mutation was detected in An. funestus from
Gankette Balla, as previously reported in other popula-
tions of this species [9, 11, 25]. Indeed, the VGSC gene
sequencing analysis detected only the TTA 1014 codon in-
dicating that they do not have the L1014F (TTA-to-TTT)
or L1014S (TTA-to-TCA) kdr mutation (Additional file
10: Figure S1) commonly found in An. gambiae.
Table 1 Transcripts from detoxification genes with lambda-cyhalothrin resistance upregulated in various comparisons (R-C, R-S
and C-S) in Gankette Balla (Continued)
CUST_7498_PI426302897 Afun007498 3.69 2.81 heat shock cognate 70 protein
CUST_7302_PI426302897 Afun007302 3.34 3.86 heat shock 70 kda protein cognate 4
CUST_5336_PI426302897 Afun005336 2.94 4.69 heat shock cognate 70 kda protein
CUST_2701_PI406199769 combined_c1362 2.77 2.35 heat shock protein 70 -interacting protein
CUST_2184_PI406199772 CD578312.1 2.30 3.18 82 kda heat shock protein
CUST_3246_PI426302897 Afun003246 5.12 5.83 aldehyde oxidase
CUST_11963_PI426302897 Afun011963 4.56 4.55 aldehyde oxidase
CUST_718_PI406199788 gb-PX4B 4.32 4.43 oxidase peroxidase
CUST_199_PI426302897 Afun000199 3.04 3.46 chorion peroxidase
CUST_7400_PI426302897 Afun007400 2.57 3.12 thioredoxin-dependent peroxidase
CUST_8347_PI426302897 Afun008347 5.07 3.21 chymotrypsin 1
CUST_11697_PI426302897 Afun011697 3.04 4.34 chymotrypsin bii
CUST_7894_PI426302897 Afun007894 5.50 4.34 trypsin delta gamma
CUST_1313_PI426302897 Afun001313 (CYP9J5) 2.93 2.67 cytochrome p450
CUST_11293_PI426302897 Afun011293 4.22 4.97 AGAP012443-PA [Anopheles gambiae str. PEST]
CUST_4992_PI426302897 Afun004992 3.46 2.61 AGAP010545-PA [Anopheles gambiae str. PEST]
CUST_9542_PI426302897 Afun009542 2.32 2.58 AGAP000321-PA [Anopheles gambiae str. PEST]
CUST_9600_PI406199769 combined_c4862 1.51 2.53 ankyrin unc44
Abbreviations: R-C Resistant-Control, R-S Resistant-Susceptible, C-S Control-Susceptible
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Discussion
This study provides the first assessment of the suscepti-
bility and mechanisms to the main insecticides used in
public health of An. funestus population from Senegal.
Susceptibility / resistance to lambda-cyhalothrin
The results from this study show that An. funestus popu-
lation from Gankette Balla is resistant to pyrethroids
and DDT. In addition, suspected resistance was observed
to bendiocarb and dieldrin. Resistance of An. funestus to
different classes of insecticides has already been reported
in West Africa [10, 11, 26], East Africa [9, 17] and in
southern Africa [3, 4, 24, 27]. In Senegal, resistance to
pyrethroids and DDT has already been reported in other
malaria vectors such as An. gambiae (s.l.) [12–14, 28]
and An. pharoensis [28].
On the other hand, our study revealed a resistance
pattern where type II pyrethroid (lambda-cyhalothrin /
deltamethrin) seems to be more involved compared to
type I pyrethroids (permethrin). This resistance profile is
different to that observed in An. funestus in Benin [11]
where resistance is higher against type I pyrethroids.
This difference could suggest the existence of a different
resistance mechanism for pyrethroid resistance in Senegal
compared to Benin. Indeed, some cytochrome P450s ex-
hibit specificity for either or the two types of pyrethroids
[29, 30]. However, the observed resistance profile is similar
to that reported in East Africa [17] and South Africa [31].
The full susceptibility observed for malathion is similar
for all tests performed so far on An. funestus populations
across Africa indicating that this insecticide could be used
as an alternative to pyrethroids, carbamates and DDT in
Indoor Residual Spraying (IRS) control program directed
against this species [32].
The source of the lambda-cyhalothrin resistance ob-
served in Gankette Balla remains unknown although the
intense use of this insecticide in the agricultural sector
could be a contributing factor. Indeed, due to the per-
manent availability of water around the Senegal River
basin, yearly cultivation is well developed in Gankette
Balla and pyrethroids are well represented in the pesti-
cides used. This assumption is reinforced by the fact that
the resistance of other malaria vectors to lambda-
cyhalothrin was observed in areas of high agricultural
pressures in Senegal [28]. Moreover, the link between
the resistance of An. gambiae (s.l.) to insecticides and in-
tensive use of pesticides has been already reported in
areas where agriculture is highly developed [33–35].
In addition, another source of selection pressure could
be likely linked to the use of type two pyrethroids in-
secticides (Deltamethrin) in treated bed nets in malaria
vector control programs. In fact, the village of Gankette
Balla was included during the scaling-up coverage with
Fig. 3 Gene expression analysis. a q-RT PCR expression Profile of selected candidate genes in An. funestus resistant to lambda-cyhalothrin.
b Correlation between the microarray and qRT-PCR fold change data for the selected candidates genes
Fig. 4 Polymorphic sites at the exon 20 fragment of the VGSC gene
in wild type An. funestus from Gankette Balla. Only polymorphic sites
are shown and these are numbered from the beginning of each
aligned sequence. Dots mean identity with the first sequence.
A number has been given to each haplotype. The column (N)
indicates the number of individuals sharing the haplotype
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insecticide-treated nets against malaria in Senegal through
the “Pal Fleuve” program in 2006.
Furthermore, the IRS campaign using the lambda-
cyhalothrin initiated a year later (2007) in the district of
Richard Toll (lower valley of the Senegal River) could
have been an additional contributing factor. Indeed, two
years after this campaign, a lambda-cyhalothrin resistance
in An. gambiae (s.l.) was observed in this area [28] and a
link between this resistance and that observed in our
study is not to exclude as previous studies have shown the
existence of strong gene flow between populations of An.
funestus in the lower valley and that of the area of Lake
Guiers [36]. The resistance of An. funestus to lambda-
cyhalothrin and deltamethrin may represent a potential
threat to the success of the future vector control program
directed against this major vector especially as pyrethroids
are the only insecticide used for the impregnation of
mosquito nets. This is a serious concern as other vectors
of the study area are resistant to pyrethroids [28]. If such
resistance is not managed properly, it can still be selected
by the current vector control program (Insecticide-
treated nets and IRS) to a level that will seriously
affect the success of future programs against this
major vector. A spread of the observed resistance in
Gankette Balla is a concern for the continued effect-
iveness of pyrethroid-based interventions against An.
funestus in Senegal.
Metabolic resistance mechanism is driving
lambda-cyhalothrin resistance
Analysis of the transcription profile of the Gankette
Balla sample supported the importance of metabolic
resistance mechanism in the observed pyrethroid resis-
tance in this An. funestus population as previously
reported [32]. The importance of metabolic resistance
mechanisms is shown through the consistent overex-
pression of genes involved in insecticide detoxification
such as cytochrome P450 genes, GSTs, aldehyde oxi-
dases and other gene families previously associated in
resistance of An. funestus to insecticides.
The P450 CYP6M7 was consistently the most over-
expressed detoxification gene in lambda-cyhalothrin
exposed mosquitoes compared to the FANG susceptible
strain as well as to the unexposed mosquitoes. This gene
was shown to be able to metabolise several pyrethroids
including lambda-cyhalothrin [37], further supporting
the likelihood that it could be the main resistance gene
in this An. funestus population. A key role of such P450
gene will be in line with the common implication of the
cytochrome P450 family genes in insecticide resistance
as previously reported in several populations of An.
funestus [3, 37–39], An. gambiae (s.l.) [40], An. albima-
nus [41] and An. minimus [42]. This is also reported in
several other insects [43–45]. More specifically, the role
of cytochrome P450 in pyrethroid resistance has been
reported in An. funestus from Benin [11], Ghana [10],
Uganda [17], Mozambique [24, 27, 46, 47], Kenya [8]
and Malawi [3], as well as in the laboratory resistant
strain to permethrin [38, 48].
The overexpression of the CYP6M7 gene in lambda-
cyhalothrin resistant and non-exposed mosquitoes, com-
pared to the susceptible strain suggests that it plays a
key role in pyrethroid metabolic resistance in An. funestus
in Gankette Balla similar to recent reports for the impor-
tant role of this gene in Zambia [6, 37]. Surprisingly, one
of the duplicated P450 genes, CYP6P9a, which has been
shown to play a main role in pyrethroid resistance in
southern populations of An. funestus [3, 38, 39, 49] was
not overexpressed at all. The complete absence of overex-
pression of CYP6P9a indicates that the resistance mech-
anism in Senegal is different to that observed in southern
Africa. A similar difference is also observed for the GSTe2
gene which is not overexpressed at all in the Gankette
Balla population whereas it was among the highest over-
expressed in a DDT and pyrethroid resistant population
from Benin, another West Africa country. It will be inter-
esting to investigate the role of other GST genes overex-
pressed in the Gankette Balla population such as GSTd3
and GSTd1-5 to see what role they play in the observed
DDT resistance.
Furthermore, the overexpression of several other genes
from the microarray analysis suggests that in addition to
CYP6M7, other genes may also play a role or involved
in subsequent phases of pyrethroid detoxification.
Further functional characterisation studies will help to
establish these roles.
Conclusions
This study has provided the first assessment of the sus-
ceptibility to the main insecticides used in public health
of an An. funestus population from Senegal and also
explored the possible mechanisms responsible for the
pyrethroid resistance observed. The resistance profile
observed in the Gankette Balla population highlights
the need for further studies to assess the extent and the
geographical distribution of these resistances in An.
funestus populations in Senegal as well as an assess-
ment of its impact on malaria control programs. This
will improve the implementation and management of
future control programs against this important malaria
vector in Senegal and in Africa in general.
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